- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
F
FLGT
Fulgent Genetics
27.85
-0.04-0.14%After Hours: 27.50 -0.35 -1.26%18:05 01/09 EST
OPEN/PREV CLOSE27.76/27.89
TODAY RANGE27.73-28.44
VOL228.49K
MARKET CAP860.91M
52 WEEK RANGE14.57-31.04
AVG VOL (3M)271.46K
% TURNOVER0.74%
TURNOVER--
P/E (TTM)-19.8701
% RANGE2.55%
EPS(TTM)-1.4016
P/E(FORWARD)-19.0753
P/B0.7632
BVPS36.49
DIVIDEND--
P/S3.030
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP579.38M
SHARES OUTSTANDING30.91M
NEXT EARNINGS02/26-03/02
FREE FLOAT20.80M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
NASDAQ·12/23/2025 17:35
FLGT to Acquire Bako & StrataDx Assets to Expand Pathology Platform
Dow Jones·12/22/2025 22:21
Fulgent Genetics to Acquire Assets From Bako, StrataDx for $55.5M
TipRanks·12/22/2025 21:33
Fulgent Genetics expands diagnostics with major dermatopathology deals
TipRanks·12/22/2025 21:15
Fulgent Genetics to acquire Bako Diagnostics and StrataDx
Reuters·12/22/2025 21:10
Fulgent Genetics to Acquire Bako Diagnostics and StrataDx for $55.5 Million
Reuters·12/22/2025 21:10
FULGENT GENETICS INC - TO BUY BAKO AND STRATADX FOR $55.5 MLN
Dow Jones·12/22/2025 21:10
Press Release: Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx
Dow Jones·12/22/2025 21:10
*Fulgent Genetics Agrees To Acquire Bako Diagnostics And StrataDx >FLGT
Dow Jones·12/22/2025 21:10
Press Release: Fulgent Genetics Agrees to Acquire -2-
Reuters·12/08/2025 20:32
Fulgent Genetics Inc. Publishes Transcript of Q3 2025 Earnings Call
TipRanks·12/04/2025 02:08
Top Executives Cash Out on Fulgent Genetics Stock!
Reuters·12/03/2025 22:04
Fulgent Genetics Chief Scientific Officer Hanlin Gao Sells Common Shares
Seeking Alpha·12/02/2025 13:05
Fulgent Genetics: From Genetic Code To Cancer Cure - Why I Assign A Hold Rating
Reuters·12/02/2025 02:15
Fulgent Genetics Chief Scientific Officer Hanlin Gao Reports Sale of Common Shares
Same Industry
Name/Symbol
Change%
Price